Discover 1,900 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,900
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase 3, Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase 1, Recruiting
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
for
Cigarette Smoking, E-cigarette Use
Location: Roanoke VA
Sponsor: Virginia Polytechnic Institute and State University
Sex: All
Age: 21+
Code: NCT07161050
Recruiting
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Criterium, Inc.
Sex: All
Age: 18+
Code: NCT06992258
Phase 2, Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Hackensack NJ, Richmond VA, Pittsburgh PA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase 2, Recruiting
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Charlottesville VA, Pittsburgh PA, Wesley Chapel FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07012031
Phase 1, Phase 2, Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
for
Healthy Adults
Location: Milford CT, Philadelphia PA, Washington D.C. DC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07431853
Phase 2, Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for
Peripheral Arterial Disease
Location: Levis, Laval, Virginia Beach VA, Bowie MD, Camp Hill PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07223593
Phase 3, Recruiting
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Willow Grove PA, Richmond VA, Fairfax VA, Rochester NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
for
Velopharyngeal Insufficiency, Head and Neck Cancer,
Location: Charlottesville VA
Sponsor: Vanessa Torrecillas
Sex: All
Age: 18+
Code: NCT07264036
Recruiting
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
for
Coronary Artery Disease (CAD)
Location: Roslyn NY, Camden NJ, Wynnewood PA, York PA,
Sponsor: HeartFlow, Inc.
Sex: All
Age: 18+
Code: NCT07479433
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Westbrook ME, Lebanon NH, Summit NJ, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Montreal, Philadelphia PA, Norfolk VA, Ottawa, Salem VA,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase 2, Recruiting
Psilocybin for Prolonged Grief Disorder
for
Prolonged Grief Disorder
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18 - 65
Code: NCT06724289
Early Phase 1, Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
for
Advanced Solid Tumors
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07161414
Phase 1, Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Providence RI, Teaneck NJ, Syracuse NY, Fairfax VA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase 2, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, Hartford CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
for
Progressive Pulmonary Fibrosis,
Location: Farmington CT, New Haven CT, New York NY,